Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 50.03B | 50.30B | 46.19B | 43.45B | 39.28B |
Gross Profit | 10.51B | 10.01B | 9.40B | 8.68B | 7.58B |
EBITDA | 5.92B | 6.33B | 5.83B | 5.48B | 4.46B |
Net Income | 3.66B | 4.29B | 4.09B | 3.47B | 2.77B |
Balance Sheet | |||||
Total Assets | 47.15B | 44.14B | 40.66B | 36.81B | 32.66B |
Cash, Cash Equivalents and Short-Term Investments | 19.67B | 18.81B | 15.35B | 15.18B | 12.38B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 11.73B | 10.96B | 10.78B | 10.30B | 9.04B |
Stockholders Equity | 35.41B | 33.17B | 29.88B | 26.52B | 23.62B |
Cash Flow | |||||
Free Cash Flow | 3.46B | 4.65B | 1.55B | 3.47B | 1.63B |
Operating Cash Flow | 3.85B | 5.05B | 2.00B | 3.73B | 2.00B |
Investing Cash Flow | 6.41B | -8.70B | -1.01B | -344.00M | -583.00M |
Financing Cash Flow | -1.41B | -894.00M | -818.00M | -607.00M | -520.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥34.20B | 6.79 | 2.37% | 55.72% | 97.54% | ||
80 Outperform | ¥1.17T | 19.22 | 17.11% | 3.84% | 20.18% | 23.93% | |
79 Outperform | $6.22T | 30.47 | 10.52% | 0.59% | -0.35% | 32.66% | |
74 Outperform | ¥1.43T | 28.96 | 1.54% | 33.00% | 21.00% | ||
72 Outperform | $2.55T | 22.01 | 8.93% | 1.69% | 4.84% | 10.24% | |
68 Neutral | ¥242.89B | 15.23 | 6.64% | 2.42% | 9.16% | -0.19% | |
68 Neutral | ¥38.60B | 10.71 | 3.21% | <0.01% | -17.60% |